We are live on ! Find out more
PRDS

Pardes Biosciences, Inc. Common Stock
PRDS

Delisted

PRDS was delisted on the 30th of August, 2023.

Back to rankings

75 hedge funds and large institutions have $176M invested in Pardes Biosciences, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 75 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
+75
Holders Change %
–
% of All Funds
1.32%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
75
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$17.7M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$10.3M
3
FCM
Farallon Capital Management
California
+$10.3M
4
JCM
JS Capital Management
New York
+$10.3M
5
PHS
PFM Health Sciences
California
+$10.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
26
Aristeia Capital
Connecticut
$1.61M +$1.67M +161,566 New
BCM
27
BlueCrest Capital Management
Jersey
$1.49M +$1.55M +150,000 New
EC
28
EcoR1 Capital
California
$1.49M +$1.55M +150,000 New
HighTower Advisors
29
HighTower Advisors
Illinois
$1.39M +$1.44M +138,988 New
MIM
30
Monashee Investment Management
Massachusetts
$1.25M +$1.29M +125,000 New
Marshall Wace
31
Marshall Wace
United Kingdom
$1.21M +$1.26M +121,440 New
Balyasny Asset Management
32
Balyasny Asset Management
Illinois
$1.2M +$1.24M +120,000 New
SCM
33
Shaolin Capital Management
Florida
$1.2M +$1.24M +120,028 New
ACM
34
Altai Capital Management
California
$996K +$1.03M +100,000 New
CCM
35
Context Capital Management
California
$996K +$1.03M +100,000 New
CH
36
CVI Holdings
Delaware
$996K +$1.03M +100,000 New
GL
37
Governors Lane
New York
$996K +$1.03M +100,000 New
LOAMU
38
Lombard Odier Asset Management (USA)
New York
$996K +$1.03M +100,000 New
CL
39
CSS LLC
Illinois
$842K +$875K +84,624 New
MAM
40
Melqart Asset Management
United Kingdom
$717K +$745K +72,000 New
HF
41
HRT Financial
New York
$702K +$729K +70,517 New
PC
42
Periscope Capital
Ontario, Canada
$650K +$675K +65,300 New
MF
43
Magnetar Financial
Illinois
$510K +$529K +51,204 New
Nomura Holdings
44
Nomura Holdings
Japan
$501K +$517K +50,000 New
AA
45
AQR Arbitrage
Connecticut
$498K +$517K +50,000 New
DKCM
46
Davidson Kempner Capital Management
New York
$498K +$517K +50,000 New
PSAMP
47
P. Schoenfeld Asset Management (PSAM)
New York
$498K +$517K +50,000 New
RCM
48
Radcliffe Capital Management
Pennsylvania
$498K +$517K +50,000 New
TD Asset Management
49
TD Asset Management
Ontario, Canada
$442K +$459K +44,398 New
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$441K +$458K +44,247 New
1
2
3

PRDS Hedge Fund Activity: Q1 2021 in Review

75 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Pardes Biosciences, Inc. Common Stock (PRDS) for Q1 2021, worth a combined $176M.

Buyers outnumbered sellers: 75 funds opened new PRDS positions and 0 closed out — a net gain of 75 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $17.7M.

  • 75 institutional investors held Pardes Biosciences, Inc. Common Stock (PRDS) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $176M of Pardes Biosciences, Inc. Common Stock stock for Q1 2021.
  • 75 funds opened new Pardes Biosciences, Inc. Common Stock positions in Q1 2021 and 0 closed out, a net change of +75 holders.
  • The largest Pardes Biosciences, Inc. Common Stock buyer in Q1 2021 was T. Rowe Price Associates, an estimated $17.7M added.

Based on aggregated 13F filings for Q1 2021.